Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Maya Gottfried
ResearcherPublications, citations & collaboration network
276
Works
26,415
Citations
44
h-index
86
i10-index
IDs:OpenAlex
How has Maya Gottfried's publication output changed over time?
ScholarIQpublication output · 2016–2019
Output grew0% over the shown period — from 1 works in 2016 to 1 in 2019.
1
1
20162019
What are the most-cited papers on Maya Gottfried?
ScholarIQmost cited works
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Melanie A. Leiby, Gregory M. Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R. Brahmer
New England Journal of Medicine. 201610,151 CitationsOPEN ACCESS
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto, Anna Maria Di Giacomo, Ana De Jesus‐Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R. Hansen, Sarina A. Piha‐Paul, Toshihiko Doi, Bo Gao, Hyun Cheol Chung, José A. López-Martín, Yung-Jue Bang, Ronnie Shapira Frommer, Manisha H. Shah, Razi Ghori, Andrew K. Joe, Scott K. Pruitt, Luis A. Díaz
Journal of Clinical Oncology. 20192,999 CitationsOPEN ACCESS
Related on ScholarIQ
Meir Medical Center
University
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Paper
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Paper
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Research Studies
Topic